Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.54 CHF | -0.51% | +4.78% | +5.60% |
08:14am | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.60% | 201B | |
+25.49% | 653B | |
+26.29% | 556B | |
-6.29% | 354B | |
+20.52% | 331B | |
+4.13% | 296B | |
+12.58% | 233B | |
-9.73% | 193B | |
-6.05% | 144B | |
-11.72% | 143B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : lung cancer drug fails another Phase III trial